Literature DB >> 3532330

Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.

J R Sporn, O R McIntyre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3532330

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  10 in total

1.  New treatments in myeloma--is cure possible?

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

Review 2.  The evolution of stem-cell transplantation in multiple myeloma.

Authors:  Sarakshi Mahajan; Nidhi Tandon; Shaji Kumar
Journal:  Ther Adv Hematol       Date:  2018-03-05

3.  Treatment of refractory multiple myeloma with the vincristine-adriamycin-dexamethasone (VAD) regimen.

Authors:  W Stenzinger; A Blömker; W Hiddemann; J van de Loo
Journal:  Blut       Date:  1990 Aug-Sep

Review 4.  Multiple myeloma. New treatment options.

Authors:  L Camba; B G Durie
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 5.  Interleukin-6, a new target for therapy in multiple myeloma?

Authors:  M H van Oers; H C van Zaanen; H M Lokhorst
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

6.  Repeat administration of high dose melphalan in relapsed myeloma.

Authors:  J L Mansi; D Cunningham; C Viner; E Ellis; M Meldrum; S Milan; M Gore
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

7.  Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.

Authors:  A Riccardi; O Mora; S Brugnatelli; C Tinelli; R Spanedda; A De Paoli; L Barbarano; M Di Stasi; C Bergonzi; M Giordano; C Delfini; G Nicoletti; E Rinaldi; L Piccinini; D Valentini; E Ascari
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  Thalidomide and its analogues in the treatment of Multiple Myeloma.

Authors:  Tahir Latif; Nabeel Chauhan; Rashid Khan; Andrea Moran; Saad Z Usmani
Journal:  Exp Hematol Oncol       Date:  2012-09-11

9.  The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma.

Authors:  Maurizio Chiriva-Internati; Raffaele Ferrari; Madhavi Prabhakar; Yuefei Yu; Luigi Baggoni; Jorge Moreno; Nicoletta Gagliano; Nicola Portinaro; Marjorie R Jenkins; Eldo E Frezza; Fred Hardwicke; Nicholas D'Cunha; Wmartin Kast; Everardo Cobos
Journal:  J Transl Med       Date:  2008-04-02       Impact factor: 5.531

Review 10.  Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.

Authors:  Fortunato Morabito; Giovanni Tripepi; Enrica Antonia Martino; Ernesto Vigna; Francesco Mendicino; Lucio Morabito; Katia Todoerti; Hamdi Al-Janazreh; Graziella D'Arrigo; Filippo Antonio Canale; Giovanna Cutrona; Antonino Neri; Massimo Martino; Massimo Gentile
Journal:  Drug Des Devel Ther       Date:  2021-07-08       Impact factor: 4.162
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.